Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning
Open Access
- 27 January 2010
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 16 (6), 838-847
- https://doi.org/10.1016/j.bbmt.2010.01.011
Abstract
No abstract availableKeywords
Funding Information
- National Fund
- Anti-Cancer Center (CAC)
- Belgian National Cancer Plan, and the Belgian Foundation against Cancer (FBC)
This publication has 49 references indexed in Scilit:
- Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic LeukemiaTransplantation and Cellular Therapy, 2009
- Salvage Allogeneic Hematopoietic Cell Transplantation with Fludarabine and Low-Dose Total Body Irradiation after Rejection of First AllograftsTransplantation and Cellular Therapy, 2009
- Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic LeukemiaClinical Cancer Research, 2009
- What Is the Role for Donor Natural Killer Cells after Nonmyeloablative Conditioning?Transplantation and Cellular Therapy, 2009
- Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trialLeukemia, 2008
- Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioningHaematologica, 2008
- Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningBlood, 2007
- Extended Mycophenolate Mofetil and Shortened Cyclosporine Failed to Reduce Graft-versus-Host Disease after Unrelated Hematopoietic Cell Transplantation with Nonmyeloablative ConditioningTransplantation and Cellular Therapy, 2007
- Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first‐line treatmentCancer, 2005
- Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or LymphomaNew England Journal of Medicine, 1989